What we know about anti-HIV drugs.
D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004279:DNA, Viral; D016049:Didanosine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D019259:Lamivudine; D012367:RNA, Viral; D018119:Stavudine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D016047:Zalcitabine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use
D000998:Antiviral Agents; D004279:DNA, Viral; D012367:RNA, Viral; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine; D018119:Stavudine; D016049:Didanosine